Monitoring Agency report for the quarter ended 31st March, 2026 in respect to utilization of funds raised through Initial Public Offer (IPO) of the Company
QUADFUTURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings Limited, the monitoring agency for Quadrant Future Tek's Rs. 290 crore IPO (January 2025), has submitted its Q4FY26 report with several observations. The company reported significant losses: Rs. 19.68 crore in FY25 and Rs. 44.08 crore in 9MFY26, primarily due to ongoing investments in the KAVACH train control project. The final RDSO approval for KAVACH remains pending, causing continued losses. A key compliance issue was flagged: board approval for Q4FY26 general corporate purpose utilization was obtained only in April 2026 (retroactively ratified), not during the quarter as required. Rs. 22.88 crore of IPO proceeds remain unutilized as of March 31, 2026, with Rs. 22.73 crore sitting idle under the Electronic Interlocking System object whose timeline expired in FY26. The company reallocated Rs. 2 crore from other objects to general corporate purposes without prior shareholder approval.
The pending KAVACH approval and project delays create uncertainty around revenue generation. The retroactive board approval and fund reallocations without prior shareholder consent signal weak governance practices. Investors should monitor whether the company obtains necessary approvals for timeline extensions and fund reallocations.